摘要
目的分离纯化L-苦杏仁苷对照品,建立苦杏仁药材中D-、L-苦杏仁苷的含量测定方法。方法采用YMC-Pack Ph高效液相色谱柱(250 mm×4.6 mm,5μm);乙腈-水(5∶95)为流动相;流速:1.00 mL·min^(-1);柱温:30℃;检测波长:207 nm。结果本实验分离纯化的L-苦杏仁苷对照品纯度为96.3%,D-、L-苦杏仁苷分别在12.118 0~363.540 0μg·mL^(-1)和1.521 6~45.648 0μg·mL^(-1)范围内具有良好的线性关系,相关系数(r)分别为0.999 8和0.999 9,平均加样回收率分别为98.86%(RSD=0.64%)和97.33%(RSD=0.87%)。结论本实验分离纯化的L-苦杏仁苷对照品纯度高,建立的高效液相色谱法(HPLC)简单可行,结果准确可靠,对D-、L-苦杏仁苷具有良好的分离效果,可用于苦杏仁药材中苦杏仁苷的质量控制,为中成药中苦杏仁苷的质量控制提供参考。
Objective To separate and purify L-amygdalin reference substance,and to establish a HPLC methodfor the content determination of D-amygdalin and L-amygdalin. Methods The YMC-Pack Ph chromatographiccolumn(250 mm×4.6 mm,5 μm) was used. The 5% acetonitrile solution was used as the mobile phase. The flowrate was 1.00 mL · min^-1. The column oven was set at 30 ℃, and the detection wavelength was set at 207 nm.Results The purity of the L-amygdalin reference substance was 96.3%. Under the above chromatographicconditions,good linear relationships were shown between peak area and the concentration of D-amygdalin and L-amygdalin in the ranges of 12.118 0-363.540 0 μg · mL^-1and 1.5216-45.6480 μg · mL^-1, respectively. Thecorrelation coefficients were 0.999 8 and 0.999 9,respectively. The average recoveries were 98.86%(RSD=0.64%)and 97.33%(RSD=0.87%),respectively. Conclusion The purity of the L-amygdalin reference substance obtainedin this experiment was high. The method is simple, feasible, and accurate with high specificity. It has goodseparation of D-and L-amygdalin,which can be used for the quality control of amygdalin in Armeniacae semenand provide reference for the quality control of amygdalin in Chinese patent medicines.
作者
许秀琼
刘建博
王硕辉
张志强
刘小虹
宋健平
王振华
XU Xiuqiong;LIU Jianbo;WANG Shuohui;ZHANG Zhiqiang;LIU Xiaohong;SONG Jianping;WANG Zhenhua(Guangzhou University of Chinese Medicine,Guangzhou 510006 Guangdong,China;The First Affiliated Hospital of Guangzhou University of Chinese Medicine,Guangzhou 510400 Guangdong,China)
出处
《中药新药与临床药理》
CAS
CSCD
北大核心
2019年第1期94-98,共5页
Traditional Chinese Drug Research and Clinical Pharmacology
基金
国家中医药管理局国际合作专项(GZYYGJ2018010)
广东省省级重大项目(2016KZDXM030)
广东省中医药局项目(粤中医办函【2015】102号)
广州市对外科技合作计划(201807010007)
白云区科技计划项目(2016KJ007)